215 related articles for article (PubMed ID: 25335552)
1. Preliminary evaluation of urinary soluble Met as a biomarker for urothelial carcinoma of the bladder.
McNeil BK; Sorbellini M; Grubb RL; Apolo A; Cecchi F; Athauda G; Cohen B; Giubellino A; Simpson H; Agarwal PK; Coleman J; Getzenberg RH; Netto GJ; Shih J; Linehan WM; Pinto PA; Bottaro DP
J Transl Med; 2014 Oct; 12():199. PubMed ID: 25335552
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection.
Urquidi V; Goodison S; Kim J; Chang M; Dai Y; Rosser CJ
Urology; 2012 May; 79(5):1185.e1-6. PubMed ID: 22386755
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer.
de Martino M; Lucca I; Mbeutcha A; Wiener HG; Haitel A; Susani M; Shariat SF; Klatte T
Eur Urol; 2015 Oct; 68(4):552-4. PubMed ID: 26138037
[TBL] [Abstract][Full Text] [Related]
4. [Correlation of genetic and cytogenetic alterations in pathological aggressiveness urothelial carcinoma of the bladder: Performance of BCA-1, a mini-array comparative genomic hybridisation-based test].
Léon P; Cancel Tassin G; Sighar K; Compérat E; Gaffory C; Ondet V; Hugonin S; Audouin M; Doizi S; Traxer O; Ciofu C; Rouprêt M; Lacave R; Cussenot O
Prog Urol; 2017; 27(8-9):451-457. PubMed ID: 28576425
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of MCM5 (ADXBLADDER) analysis in urine of men evaluated for the initial diagnosis of bladder cancer: A comparative prospective study.
Anastasi E; Maggi M; Tartaglione S; Angeloni A; Gennarini G; Leoncini PP; Sperduti I; Di Lascio G; De Stefano V; Di Pierro GB; Del Giudice F; Busetto GM; De Berardinis E; Sciarra A
Diagn Cytopathol; 2020 Nov; 48(11):1034-1040. PubMed ID: 32562513
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.
Chen L; Cui Z; Liu Y; Bai Y; Lan F
Clin Lab; 2015; 61(8):1101-8. PubMed ID: 26427157
[TBL] [Abstract][Full Text] [Related]
7. A multi-analyte assay for the non-invasive detection of bladder cancer.
Goodison S; Chang M; Dai Y; Urquidi V; Rosser CJ
PLoS One; 2012; 7(10):e47469. PubMed ID: 23094052
[TBL] [Abstract][Full Text] [Related]
8. Urinary APE1/Ref-1: A Potential Bladder Cancer Biomarker.
Choi S; Shin JH; Lee YR; Joo HK; Song KH; Na YG; Chang SJ; Lim JS; Jeon BH
Dis Markers; 2016; 2016():7276502. PubMed ID: 27057081
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic role of urinary collagens in primary human bladder cancer.
Miyake M; Morizawa Y; Hori S; Tatsumi Y; Onishi S; Owari T; Iida K; Onishi K; Gotoh D; Nakai Y; Anai S; Chihara Y; Torimoto K; Aoki K; Tanaka N; Shimada K; Konishi N; Fujimoto K
Cancer Sci; 2017 Nov; 108(11):2221-2228. PubMed ID: 28837258
[TBL] [Abstract][Full Text] [Related]
10. HOXA9, PCDH17, POU4F2, and ONECUT2 as a Urinary Biomarker Combination for the Detection of Bladder Cancer in Chinese Patients with Hematuria.
Wu Y; Jiang G; Zhang N; Liu S; Lin X; Perschon C; Zheng SL; Ding Q; Wang X; Na R; Sun J; Xu J
Eur Urol Focus; 2020 Mar; 6(2):284-291. PubMed ID: 30309818
[TBL] [Abstract][Full Text] [Related]
11. Bladder cancer risk stratification using a urinary mRNA biomarker panel - A path towards cystoscopy triaging.
Shkolyar E; Zhao Q; Mach KE; Teslovich NC; Lee TJ; Cox S; Skinner EC; Lu Y; Liao JC
Urol Oncol; 2021 Aug; 39(8):497.e9-497.e15. PubMed ID: 33766467
[TBL] [Abstract][Full Text] [Related]
12. Urinary levels of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein as a diagnostic biomarker in patients with bladder cancer.
Nitta Y; Konishi H; Makino T; Tanaka T; Kawashima H; Iovanna JL; Nakatani T; Kiyama H
BMC Urol; 2012 Sep; 12():24. PubMed ID: 22943287
[TBL] [Abstract][Full Text] [Related]
13. HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers.
Moosavi F; Giovannetti E; Saso L; Firuzi O
Crit Rev Clin Lab Sci; 2019 Dec; 56(8):533-566. PubMed ID: 31512514
[TBL] [Abstract][Full Text] [Related]
14. CCL18 in a multiplex urine-based assay for the detection of bladder cancer.
Urquidi V; Kim J; Chang M; Dai Y; Rosser CJ; Goodison S
PLoS One; 2012; 7(5):e37797. PubMed ID: 22629457
[TBL] [Abstract][Full Text] [Related]
15. Recognition of early and late stages of bladder cancer using metabolites and machine learning.
Kouznetsova VL; Kim E; Romm EL; Zhu A; Tsigelny IF
Metabolomics; 2019 Jun; 15(7):94. PubMed ID: 31222577
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of urinary level of NMP22 as a diagnostic marker for stage pTa-pT1 bladder cancer: comparison with urinary cytology and BTA test.
Del Nero A; Esposito N; Currò A; Biasoni D; Montanari E; Mangiarotti B; Trinchieri A; Zanetti G; Serrago MP; Pisani E
Eur Urol; 1999 Feb; 35(2):93-7. PubMed ID: 9933801
[TBL] [Abstract][Full Text] [Related]
17. Urinary mRNA biomarker panel for the detection of urothelial carcinoma.
Urquidi V; Netherton M; Gomes-Giacoia E; Serie D; Eckel-Passow J; Rosser CJ; Goodison S
Oncotarget; 2016 Jun; 7(25):38731-38740. PubMed ID: 27231851
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the urinary metabolic variations and the application in bladder cancer biomarker discovery.
Liu X; Cheng X; Liu X; He L; Zhang W; Wang Y; Sun W; Ji Z
Int J Cancer; 2018 Jul; 143(2):408-418. PubMed ID: 29451296
[TBL] [Abstract][Full Text] [Related]
19. Urinary oncofetal ED-A fibronectin correlates with poor prognosis in patients with bladder cancer.
Arnold SA; Loomans HA; Ketova T; Andl CD; Clark PE; Zijlstra A
Clin Exp Metastasis; 2016 Jan; 33(1):29-44. PubMed ID: 26456754
[TBL] [Abstract][Full Text] [Related]
20. A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort.
Goodison S; Ogawa O; Matsui Y; Kobayashi T; Miyake M; Ohnishi S; Fujimoto K; Dai Y; Shimizu Y; Tsukikawa K; Furuya H; Rosser CJ
J Transl Med; 2016 Oct; 14(1):287. PubMed ID: 27717367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]